Head of the Group

Prof. Dr.-Ing. Udo Reichl
Prof. Dr.-Ing. Udo Reichl
Phone: +49 391 6110 201
Fax: +49 391 6110 203
Room: N0.19

Contact Person

Annegret Frauendienst
Phone:+49 391 6110 200Fax:+49 391 6110 203

Group Page

Publications

Publications BPE group

Talk (234)

  1. 501.
    Genzel, Y.; Schulze-Horsel, J.; Reichl, U.: High Cell Density Microcarrier Process in a Wave Bioreactor for the Production of Influenza A Virus. Vaccine Technology, Puerto Vallarta, Mexiko (2006)
  2. 502.
    Genzel, Y.; Reichl, U.: Limits and benefits of the interpretation of extracellular metabolite data in mammalian cell culture. 1st Max Planck Workshop on "Metabolomics", Magdeburg, Germany (2006)
  3. 503.
    Kalbfuss, B.; Wolff, M. W.; Genzel, Y.; Zimmermann, A.; Morenweiser, R.; Reichl, U.: Chromatography-based purification of influenza A virus for the production of human whole-virion vaccines. ISPPP 2006 : 26th International Symposium on the Separation of Proteins, Peptides and Polynucleotides, Innsbruck, Austria (2006)
  4. 504.
    Kalbfuss, B.; Wolff, M. W.; Geisler, L.; Thom, V.; Reichl, U.: Konzentrierung und Aufreinigung von Influenza Viren mittels Ionenaustauscher-Membranen. 24. DECHEMA-Jahrestagung der Biotechnologen, Wiesbaden, Germany (2006)
  5. 505.
    Kalbfuss, B.; Gedicke, K.; Seidel-Morgenstern, A.; Reichl, U.: Maximizing productivity in size-exclusion chromatography of influenza virus: A modelling approach. ESBES 6 : 6th European Symposium on Biochemical Engineering Science, Salzburg, Austria (2006)
  6. 506.
    Kalbfuss, B.; Wolff, M. W.; Genzel, Y.; Zimmermann, A.; Best, C.; Morenweiser, R.; Reichl, U.: A generic purification scheme for the production of human influenza vaccines derived from serum-free mammalian cell culture. Vaccine Technology, Puerto Vallarta, Mexico (2006)
  7. 507.
    Reichl, U.: MDCK Cell Derived Influenza Vaccines: Aspects of Up- and Downstream Processing. Meeting Academy of Science, Sofia, Bulgarien (2006)
  8. 508.
    Reichl, U.: Dynamics of Influenza Virus Replication in Mammalian Cell Culture. CCEX Workshop, Vancouver, Canada (2006)
  9. 509.
    Reichl, U.: MDCK Cell derived Influenza Vaccines: Aspects of Modeling and Experimental Design in Upstream Processing. Meeting at Sanof Pasteur, Toronto, Canada (2006)
  10. 510.
    Reichl, U.: Biological Fundamentals, Models and Technologies for Vaccine Production. Perspectives of Research - Identification and Implementation of Research Topics by Organizations : Ringberg-Symposium Mai 2006, Kreuth, Germany (2006)
  11. 511.
    Reichl, U.: Mathematical Models for Mammalian Cell Growth and Virus Replication for an Influenza Vaccine Production Process. Technische Universität Berlin : Meeting, Berlin, Germany (2006)
  12. 512.
    Ritter, J. B.; Genzel, Y.; Reichl, U.: Monitoring Energy Metabolism: The Challenge of Intracellular Metabolite Analysis of Mammalian Cells in Culture. 1st Max Planck Workshop on "Metabolomics", Magdeburg, Germany (2006)
  13. 513.
    Schulze-Horsel, J.; Bock, A.; Genzel, Y.; Reichl, U.: Mammalian cell culture for influenza vaccine production: physiology during cell growth and virus propagation phase. GVC/DECHEMA-Jahrestagungen 2006 mit 24. DECHEMA-Jahrestagung der Biotechnologen, Wiesbaden, Germany (2006)
  14. 514.
    Wahl, A.; Nöh, K.; Wiechert, W.: Metabolic and Isotopic Instationary Experiments: A Simulative Study. Metabolic Engineering VI, Noordwijkerhout, The Netherlands (2006)
  15. 515.
    Wahl, S. A.; Nöh, K.; Wiechert, W.: Experiments at Metabolic and Isotopic Instationary State: An Exploratory study. Metabolic Engineering VI : From recDNA Towards Engineering Biological Systems, Noordwijkerhout, Netherlands (2006)
  16. 516.
    Wolff, M. W.; Kalbfuss, B.; Opitz, L.; Zimmermann, A.; Lehmann, S.; Reichl, U.: Downstream Process of Influenza Viruses. European BioPharm Scale-Up Congress 2006, Geneva, Switzerland (2006)
  17. 517.
    Wolff, M. W.; Kalbfuss, B.; Lehmann, S.; Morenweiser, R.; Opitz, L.; Zimmermann, A.; Reichl, U.: Downstream Processes and Glycan Characterization of MDCK-Cell Derived Influenza Virus. BioProcess Technology - Asia, Singapore (2006)
  18. 518.
    Genzel, Y.; Schulze-Horsel, J.; Möhler, L.; Sidorenko, Y.; Reichl, U.: Influenza Vaccines: Challenges in Mammalian Cell Culture Technology. 19th ESACT Meeting, Harrogate, UK (2005)
  19. 519.
    Heßeler, J.; Schmidt, J. K.; Reichl, U.; Flockerzi, D.: How to achieve coexistence in the chemostat: a combined mathematical and experimental approach. European Conference on Mathematical and Theoretical Biology (ECMTB), Dresden, Germany (2005)
  20. 520.
    Wolff, M.; Kalbfuss, B.; Morenweiser, R.; Zimmermann, A.; Reichl, U.: Chromatography-based Purification of Influenza A Virus for the Production of Human Whole-Virion Vaccines. Viral Vectors and Vaccines Conference, Austin, Texas (2005)
  21. 521.
    Wolff, M. W.; Salaklang, J.; Opitz, L.; Schwarzer, J.; Rapp, E.; Kalbfuss, B.; Reichl, U.: Development of a lectin-affinity chromatography step for the downstream processing of influenza virus vaccines. AICHE Annual Meeting 2005, Cincinnati, Ohio, USA (2005)
  22. 522.
    Genzel, Y.; König, S.; Reichl, U.: Amino acid analysis in mammalian cell culture based virus vaccine production processes. IICS : 17th annual International Ion Chromatography Symposium, Trier, Germany (2004)
  23. 523.
    Rapp, E.; Lubda, D.; Seidel-Morgenstern, A.; Reichl, U.; Tallarek, U.: Sheathless ESI-Interface for Coupling Capillary Separation Techniques to Mass Spectromety. 37. Diskussionstagung der Deutschen Gesellschaft für Massenspektrometrie, Leipzig, Germany (2004)

Poster (301)

  1. 524.
    Behne, A.; Bock, A.; Hennig, R.; Reichl, U.; Rapp, E.: Characterizing the Sweet Sites of Therapeutic Glycoproteins using glyXbox. Congress: „new and emerging technologies“, Potsdm, Germany (2017)
  2. 525.
    Bergmann, C.; Schildbach, A.; Rexer, T.; Rapp, E.; Reichl, U.; Pietzsch, M.: In-vitro synthesis of a phytanyl-pyrophosphate-linked oligosaccharide by a cascade of Alg2 and Alg11 as part of a platform for N-glycosylation of therapeutic proteins. GlycoBioTec Symposium 2017, Berlin, Germany (2017)
  3. 526.
    Bissinger, T.; Rodrigues Correia Ramos, J.; Ringeisen, J.; Genzel, Y.; Reichl, U.: Intracellular Metabolic Pool Dynamics in MDCK Suspension Cells during Growth and Influenza Virus Infection. 25th ESACT Meeting, Lausanne, Switzerland (2017)
  4. 527.
    Fortuna, A. R.; Tamargo Granados, L.; Gasczyk, C.; Grundke, S.; Toeppner, K.; Hundt, B.; Schleuss, T.; Villain, L.; Wolff, M. W.; Reichl, U.: Tangential flow filtration of influenza virus feed streams for veterinary vaccine production. ICOM 2017: International Congress on Membranes and Membrane Processes, San Francisco, USA (2017)
  5. 528.
    Hennig, R.; Bock, A.; Behne, A.; Reichl, U.; Rapp, E.: The glyXtoolTM software suite - introducing the next generation of automated high-throughput glycoprofiling. Congress: „new and emerging technologies“, Potsdm, Germany (2017)
  6. 529.
    Hoffmann, M.; Bartels, M.F.; Hennig, R.; Pioch, M.; Reichl, U.; Strahl, S.; Rapp, E.: Unravelling the Interplay between Protein O-Mannosylation and N-Glycosylation-An N-Glycomic and N-Glycoproteomic Study of Human N-Cadherin. DFG FOR 2509 Kick-off Meeting, Heidleberg, Germany (2017)
  7. 530.
    Hoffmann, M.: Unravelling the Correlation between Different ER-Based Types of Glycosylation via Glyco/Proteo-Analytics. DFG FOR 2509 Kick-off meeting, Heidelberg, Germany (2017)
  8. 531.
    Hoffmann, M.; Pioch, M.; Pralow, A.; Nguyen-Khuong, T.; Hennig, R.; Kottler, R.; Reichl, U.; Rapp, E.: Site-Specific N-and O-Glycoproteomic Analysis Using Stepped Collisional Energy Fragmentation on a Linear Iontrap/ Orbitrap Hybrid Mass Spectrometer. GlycoBioTec Symposium 2017, Berlin, Germany (2017)
  9. 532.
    Koch, S.; Benndorf, D.; Kohrs, F.; Lahmann, P.; Reichl, U.; Klamt, S.: Strategies for Modeling of Large-Scale Metabolic Models of Microbial Communities. Metabolic Pathway Analysis 2017, Bozeman, Montana, USA (2017)
  10. 533.
    Kohrs, F.; Heyer, R.; Bissinger, T.; Kottler, R.; Schallert, K.; Püttker, S.; Behne, A.; Rapp, E.; Benndorf, D.; Reichl, U.: Proteotyping of microbial communities from laboratory-scale biogas plants reveals multiple steady-states. 14th Symposium on Bacterial Genetics and Ecology (BAGECO 14), Aberdeen, Scotland (2017)
  11. 534.
    Mahour, R.; Klapproth, J.; Rexer, T.; Schildbach, A.; Pietzsch, M.; Rapp, E.; Reichl, U.: In vitro multienzymatic network for production of UDP-GlcNAc. DECHEMA Summer School 2017: Biotransformations 2017, Hannover, Germany (2017)
  12. 535.
    Mahour, R.; Klapproth, J.; Rexer, T.; Schildbach, A.; Pietzsch, M.; Rapp, E.; Reichl, U.: In vitro multienzymatic network for production of UDP-GlcNAc. GlycoBioTec Symposium 2017, Berlin, Germany (2017)
  13. 536.
    Nikolay, A.; Castilho, L.; Genzel, Y.; Reichl, U.: Process intensification of yellow fever virus and Zika virus production by perfusion bioreactors. 25th ESACT Meeting, Lausanne, Switzerland (2017)
  14. 537.
    Nikolay, A.; Castilho, L.; Genzel, Y.; Reichl, U.: Production of yellow fever virus and Zika virus in perfusion bioreactors. DECHEMA Himmelfahrtstagung "Models for Developing and Optimising Biotech Production", Neu-Ulm, Germany (2017)
  15. 538.
    Pralow, A.; Nguyen-Khuong, T.; Pioch, M.; Hennig, R.; Hoffmann, M.; Rapp, E.; Reichl, U.: Comprehensive structural and site-specific N-glycan analysis of influenza A/PR8/34 virus propagated in adherent and suspension MDCK cells. GlycoBioTec Symposium 2017, Berlin, Germany (2017)
  16. 539.
    Rexer, T.; Schildbach, A.; Rapp, E.; Reichl, U.; Pietzsch, M.: In-vitro synthesis of phytanyl-pyrophosphate-linked oligosaccharides by cascades of glycosyltransferases as basic platform for N-glycosylation of therapeutic proteins. DECHEMA Summer School 2017: Biotransformations 2017, Hannover, Germany (2017)
  17. 540.
    Schallert, K.; Zoun, R.; Heyer, R.; Muth, T.; Behne, A.; Benndorf, D.; Saake, G.; Reichl, U.: The MetaProteomeAnalyzer: a software suite for analysis of metaproteomic data in microbiome research. Proteomic Forum 2017, Potsdam, Germany (2017)
  18. 541.
    Tapia, F.; Genzel, Y.; Jordan, I.; Sandig, V.; Reichl, U.: Options for continuous virus vaccines production: options for continuous virus vaccines production: tubular plug-flow bioreactor vs. cascades of CSTRs. Integrated Continuous Biomanufacturing III, Cascais, Portugal (2017)
  19. 542.
    Zmora, P.; Moldenhauer, A. S.; Erdelt, S.; Dahlmann, F.; Sewald, K.; Zhao, Y.; Bruns, S.; Poehlmann, S.: Nafamostat is a new potent inhibitor of trypsin-independent influenza A viruses spread. 27th Annual Meeting of the Society for Virology, Marburg, Germany (2017)
  20. 543.
    Benndorf, D.; Becher, B.; Kohrs, F.; Heyer, R.; Rapp, E.; Schlüter, A.; Sczyrba, A.: An optimized bioinformatic workflow for of biogas plants. VAAM Jahrestagung, Jena, Germany (2016)
  21. 544.
    Benndorf, D.; Heyer, R.; Kohrs, F.; Schallert, K.; Muth, T.; Reichl, U.: The MetaProteomeAnalyzer software provides a complete workflow for analysis of metaproteomic data in microbiome research. International de.NBI-Symposium "Bioinformatics for Human Health & Disease", Heidelberg, Germany (2016)
  22. 545.
    Benndorf, D.; Becher, B.; Kohrs, F.; Heyer, R.; Rapp, E.; Schlüter, A.; Sczyrba, A.; Reichl, U.: An optimized bioinformatic workflow for metaproteomics of biogas plants. Annual Conference of the Association for General and Applied Microbiology (VAAM), Jena, Germany (2016)
  23. 546.
    Cajic, S.; Hennig, R.; Reichl, U.; Rapp, E.: Exploring the Complex World of Sialic Acids by xCGE-LIF. Frontiers in Sialic Acid Research Conference (SIAREC), Bad Lauterberg, Germany (2016)
  24. 547.
    Dürr, R.; Duvigneau, S.; Laske, T.; Bachmann, M.; Kienle, A.: Analyzing the impact of heterogeneity in genetically engineered cell lines for influenza vaccine production using population balance modeling. 6th IFAC Conference on Foundations of Systems Biology in Engineering (FOSBE), Magdeburg, Germany (2016)
  25. 548.
    Fischer, L.M.; Ilhan, S.; Wolff, M. W.; Reichl, U.: Purification of Influenza Virus via Continuous Chromatography. Vaccine Technology Albufeira 2016, Albufeira, Portugal (2016)
  26. 549.
    Fortuna, A. R.; Teeffelen, S. v.; Taft, F.; Villain, L.; wolff, M. W.; Reichl, U.: Optimization of sulfated cellulose membrane adsorbers for the purification of influenza virus. Vaccine Technology Albufeira 2016, Albufeira, Portugal (2016)
  27. 550.
    Hennig, R.; Cajic, S.; Bock, A.; Reichl, U.; Rapp, E.: Characterization of Species-Specific IgG Sialylation by xCGE-LIF. Frontiers in Sialic Acid Research Conference (SIAREC), Bad Lauterberg, Germany (2016)
 
Go to Editor View
loading content